PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
70.09
-1.72 (-2.40%)
Aug 28, 2026, 4:00 PM EDT - Market closed
PTC Therapeutics Employees
PTC Therapeutics had 991 employees as of December 31, 2025. The number of employees increased by 52 or 5.54% compared to the previous year.
Employees
991
Change (1Y)
52
Growth (1Y)
5.54%
Revenue / Employee
$1,017,915
Profits / Employee
-$38,731
Market Cap
5.85B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 991 | 52 | 5.54% | 991 | 0 |
| Dec 31, 2024 | 939 | -116 | -11.00% | 939 | 0 |
| Dec 31, 2023 | 1,055 | -355 | -25.18% | 988 | 67 |
| Dec 31, 2022 | 1,410 | 233 | 19.80% | 1,402 | 8 |
| Dec 31, 2021 | 1,177 | 210 | 21.72% | 1,167 | 10 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Cogent Biosciences | 258 |
| Definium Therapeutics | 106 |
| Erasca | 103 |
| Dianthus Therapeutics | 92 |
PTCT News
- 3 days ago - PTC Therapeutics to Participate in Upcoming Investor Conferences - PRNewsWire
- 6 days ago - PTC Therapeutics announces new sephience data - TheFly
- 6 days ago - PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile - PRNewsWire
- 14 days ago - PTC Therapeutics to acquire ST-920 from Sangamo Therapeutics - TheFly
- 14 days ago - PTC Therapeutics price target raised to $109 from $106 at Wells Fargo - TheFly
- 14 days ago - PTC Therapeutics price target raised to $122 from $120 at Barclays - TheFly
- 18 days ago - PTC Therapeutics Transcript: Investor update - Transcripts
- 18 days ago - PTC Therapeutics Press release: Investor update - Filings